Vir Biotechnology, Inc. revenue breakdown overview

Vir Biotechnology, Inc. revenue for the last year amounted to 74.20 M USD, the most of which — 74.20 M USD — came from its highest performing source at the moment, Antibody-based Therapies, the year earlier bringing 86.18 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Vir Biotechnology, Inc. 74.20 M USD, and the year before that — 86.18 M USD.